These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11248590)

  • 1. Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits.
    Fredriksson A; Schröder N; Eriksson P; Izquierdo I; Archer T
    Parkinsonism Relat Disord; 2001 Apr; 7(2):97-105. PubMed ID: 11248590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration.
    Fredriksson A; Archer T
    Behav Brain Res; 2003 Feb; 139(1-2):31-46. PubMed ID: 12642174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.
    Archer T; Fredriksson A
    Neurochem Res; 2007 Oct; 32(10):1625-39. PubMed ID: 17694434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postnatal iron overload destroys NA-DA functional interactions.
    Fredriksson A; Archer T
    J Neural Transm (Vienna); 2007 Feb; 114(2):195-203. PubMed ID: 16932993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period.
    Fredriksson A; Schröder N; Eriksson P; Izquierdo I; Archer T
    Brain Res Dev Brain Res; 2000 Jan; 119(1):65-74. PubMed ID: 10648873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice.
    Fredriksson A; Eriksson P; Archer T
    J Neural Transm (Vienna); 2006 Feb; 113(2):137-50. PubMed ID: 16082515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of noradrenaline denervation on MPTP-induced deficits in mice.
    Archer T; Fredriksson A
    J Neural Transm (Vienna); 2006 Sep; 113(9):1119-29. PubMed ID: 16362627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenergic-Dopaminergic Interactions Due to DSP-4-MPTP Neurotoxin Treatments: Iron Connection.
    Archer T
    Curr Top Behav Neurosci; 2016; 29():73-86. PubMed ID: 26718588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN).
    Fredriksson A; Eriksson P; Archer T
    J Neural Transm (Vienna); 1997; 104(6-7):579-92. PubMed ID: 9444559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice.
    Fredriksson A; Fredriksson M; Eriksson P
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):258-64. PubMed ID: 8212007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antihypokinesic action of alpha2-adrenoceptors upon MPTP-induced behaviour deficits in mice.
    Archer T; Fredriksson A
    J Neural Transm (Vienna); 2003 Feb; 110(2):183-200. PubMed ID: 12589577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.
    Fredriksson A; Archer T
    Neurotox Res; 2006 Jun; 9(4):305-12. PubMed ID: 16782590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub/suprathreshold doses of L-dopa upon motor behaviour of MPTP-treated mice.
    Fredriksson A; Palomo T; Archer T
    J Neural Transm (Vienna); 1999; 106(9-10):889-909. PubMed ID: 10599871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys.
    Schneider JS
    Brain Res; 1990 Nov; 534(1-2):25-36. PubMed ID: 2073585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MPTP-induced hypoactivity in mice: reversal by L-dopa.
    Fredriksson A; Plaznik A; Sundström E; Jonsson G; Archer T
    Pharmacol Toxicol; 1990 Oct; 67(4):295-301. PubMed ID: 2077520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice.
    Perez V; Unzeta M
    Neurochem Int; 2003 Feb; 42(3):221-9. PubMed ID: 12427476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPTP-induced behavioural and biochemical deficits: a parametric analysis.
    Fredriksson A; Archer T
    J Neural Transm Park Dis Dement Sect; 1994; 7(2):123-32. PubMed ID: 7710664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents.
    Tariq M; Khan HA; Al Moutaery K; Al Deeb S
    Brain Res Bull; 2001 Jan; 54(1):77-82. PubMed ID: 11226716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse.
    Hallman H; Lange J; Olson L; Strömberg I; Jonsson G
    J Neurochem; 1985 Jan; 44(1):117-27. PubMed ID: 3880581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.